- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02752386
Biofeedback Training to Control Pain Processing
September 24, 2019 updated by: Jamie Rhudy, University of Tulsa
The purpose of this study is to test whether a novel form of biofeedback training can help individuals regulate their pain more effectively.
Study Overview
Detailed Description
Relaxation is a low-cost treatment for managing pain with little or no side effects.
The proposed study will use a novel biofeedback procedure to try to enhance the ability of relaxation to engage pain inhibition.
Specifically, a biofeedback system will be used to provide training in conditioned pain regulation.
The biofeedback system will monitor the trainee's level of sympathetic arousal and use it to control the intensity of painful stimulations delivered to the trainee during biofeedback.
So when the trainee successfully relaxes (and reduced arousal), the intensity is lowered and produces pain relief.
Efficacy of the training will be tested in a randomized controlled trial in which healthy, pain-free trainees are assigned to receive 3 training sessions or 3 sessions of a control procedure (2 other procedures will serve as controls; 3 groups total).
The aim will be to assess whether the training results in inhibition of experimental pain and the nociceptive flexion reflex (NFR, a physiological marker of spinal pain signaling) to determine whether brain-to-spinal cord inhibitory circuits are engaged.
Study Type
Interventional
Enrollment (Actual)
94
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74104
- University of Tulsa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy pain free individuals over the age of 18.
Exclusion Criteria:
- under 18 years of age (given the nature of the study)
- history of serious cardiovascular, neuroendocrine, or neurological disorders
- hypertension (due to a relationship between blood pressure and pain);5 4) history of chronic pain
- current opioid, antidepressant, or anxiolytic medication use
- psychosis or apparent cognitive impairment
- body mass index>35 (due to difficulty eliciting an NFR in persons with high adiposity)
- inability to understand and read English (questionnaires and consent form are in English)
- recent use of an over-the-counter pain medication (within the last 24 hours) or narcotic medication (within the last two weeks)
- history of panic attacks. No one will be excluded based on ethnic, racial, or gender characteristics.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Biofeedback Training 1
Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction.
Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback.
Electric stimulations will be delivered throughout the biofeedback to provide pain relief when relaxation is achieved.
|
Participants will received biofeedback training to reduce arousal and pain
|
|
Active Comparator: Biofeedback Training 2
Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction.
Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback.
Electric stimulations will be delivered throughout the biofeedback to provide a painful context in which to practice relaxing.
|
Participants will received biofeedback training to reduce arousal and pain
|
|
Active Comparator: Biofeedback Training 3
Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction.
Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback.
|
Participants will received biofeedback training to reduce arousal and pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in nociceptive flexion reflex threshold
Time Frame: Assessed at the beginning and end of each of the 3 biofeedback training days
|
physiological marker of pain processing
|
Assessed at the beginning and end of each of the 3 biofeedback training days
|
|
Change in temporal summation of pain
Time Frame: Assessed at the beginning and end of each of the 3 biofeedback training days
|
marker of pain facilitation (change in pain rating 0-100 that occurs in response to a mechanical stimulus series)
|
Assessed at the beginning and end of each of the 3 biofeedback training days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Actual)
July 1, 2018
Study Completion (Actual)
July 31, 2018
Study Registration Dates
First Submitted
April 19, 2016
First Submitted That Met QC Criteria
April 26, 2016
First Posted (Estimate)
April 27, 2016
Study Record Updates
Last Update Posted (Actual)
September 26, 2019
Last Update Submitted That Met QC Criteria
September 24, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- TU1560
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.